Skip to main content
Article thumbnail
Location of Repository

Renal dysfunction is associated with shorter telomere length in heart failure

By L. S. Wong, P. van der Harst, R. A. de Boer, V. Codd, J. Huzen, N. J. Samani, H. L. Hillege, A. A. Voors, W. H. van Gilst, T. Jaarsma and D. J. van Veldhuisen


Background Renal dysfunction is a frequent comorbidity associated with high mortality in patients with chronic heart failure (CHF). The intrinsic biological age might affect the ability of the kidney to cope with the challenging environment caused by CHF. We explored the association between leukocyte telomere length, a marker for biological age, and renal function in patients with CHF. \ud Methods and results Telomere length was determined by a real-time quantitative polymerase chain reaction in 866 CHF patients. Renal function was estimated with the simplified Modification of Diet in Renal Disease equation. The median age was 74 (interquartile range 64–79) years, 61% male, left ventricular ejection fraction of 30 (23–44)%, and the estimated glomerular filtration rate was 53 (40–68) ml/min/1.73 m2. Telomere length was associated with renal function (correlation coefficient 0.123, P < 0.001). This relationship remained significant after adjustment for age, gender, age of CHF onset (standardized-beta 0.091, P = 0.007). Also additionally adjusting for the severity of CHF and baseline differences did not change our findings. \ud Conclusion The association between shorter leukocyte telomere length and reduced renal function in heart failure suggests that intrinsic biological aging affects the ability of the kidney to cope with the systemic changes evoked by heart failure

Topics: Telomere, Renal function, Heart failure
Publisher: Springer Verlag (Germany)
Year: 2009
DOI identifier: 10.1007/s00392-009-0048-7
OAI identifier:

Suggested articles


  1. (2008). Advanced glycation endproducts in chronic heart failure. doi
  2. (2008). Aviv A doi
  3. (2008). Biological ageing and cardiovascular disease. doi
  4. (2003). Chronic kidney disease as a cardiovascular risk factor. doi
  5. (2007). Clin Res Cardiol doi
  6. (2009). Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure. doi
  7. (2004). Design and methodology of the COACH study: a multicenter randomised Coordinating Study Evaluating Outcomes of Advising and Counselling in Heart failure. doi
  8. (2009). Differential associations between renal function and ‘‘modifiable’’ risk factors in patients with chronic heart failure. doi
  9. (2006). Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. doi
  10. (2008). Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
  11. (2008). Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. doi
  12. (2006). Epidemiology of heart failure in a community-based study of subjects aged [ or = 57 years: incidence and long-term survival. doi
  13. (1993). Epidemiology of heart failure in the United States. doi
  14. (2004). Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. doi
  15. (2002). Oxidative stress shortens telomeres. doi
  16. (2008). Possible association between telomere length and renal dysfunction in patients with chronic heart failure. doi
  17. (2008). RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection. doi
  18. (2006). Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
  19. (2003). Senescence of renal cells: molecular basis and clinical implications. doi
  20. (2003). Telomere attrition and Chk2 activation in human heart failure. doi
  21. (2008). Telomere length is shorter in healthy offspring of subjects with coronary artery disease: support for the telomere hypothesis. doi
  22. (2005). Telomeres and human disease: ageing, cancer and beyond. doi
  23. (2006). Telomeres and human somatic fitness. doi
  24. (2004). Telomeres and telomerase.
  25. (2005). The severe cardiorenal syndrome: ‘Guyton revisited’.
  26. (2007). Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.